TOVX Earnings Theriva Biologics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–44 of 44
| Q2 2026 | 2026-06-30 | -0.12 | 2026-08-11 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.05 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -2.08 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -3.38 | 2025-11-12 | 10-Q |
| Q2 2026 | 2025-06-30 | -3.64 | 2026-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.55 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | -19.03 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -24.47 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -18.45 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -7.53 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -28.48 | 2025-03-06 | 10-K |
| Q3 2024 | 2023-09-30 | -20.38 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.63 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.30 | 2024-05-07 | 10-Q |
| FY 2023 | 2022-12-31 | -1.31 | 2024-03-25 | 10-K |
| Q3 2023 | 2022-09-30 | -0.87 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.59 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.31 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -1.90 | 2023-03-30 | 10-K |
| Q3 2022 | 2021-09-30 | -1.51 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.31 | 2022-08-11 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.13 | 2022-05-16 | 10-Q |
| FY 2021 | 2020-12-31 | -0.66 | 2022-03-16 | 10-K |
| Q3 2021 | 2020-09-30 | -0.52 | 2021-11-03 | 10-Q |
| Q3 2019 | 2019-09-30 | -0.79 | 2019-11-04 | 10-Q |
| Q2 2019 | 2019-06-30 | -0.48 | 2019-08-08 | 10-Q |
| Q1 2019 | 2019-03-31 | -0.25 | 2019-05-08 | 10-Q |
| FY 2018 | 2018-12-31 | -1.12 | 2019-02-27 | 10-K |
| Q3 2019 | 2018-09-30 | -2.73 | 2019-11-04 | 10-Q |
| Q2 2019 | 2018-06-30 | -1.80 | 2019-08-08 | 10-Q |
| Q1 2019 | 2018-03-31 | -0.65 | 2019-05-08 | 10-Q |
| FY 2018 | 2017-12-31 | 0.76 | 2019-02-27 | 10-K |
| FY 2018 | 2017-09-30 | -4.90 | 2019-02-27 | 10-K |
| FY 2018 | 2017-06-30 | -1.05 | 2019-02-27 | 10-K |
| FY 2018 | 2017-03-31 | -0.70 | 2019-02-27 | 10-K |
| FY 2017 | 2016-12-31 | -0.02 | 2018-02-22 | 10-K |
| FY 2017 | 2016-09-30 | -0.09 | 2018-02-22 | 10-K |
| FY 2017 | 2016-06-30 | -0.10 | 2018-02-22 | 10-K |
| FY 2017 | 2016-03-31 | -0.12 | 2018-02-22 | 10-K |
| FY 2016 | 2015-12-31 | -0.12 | 2017-03-02 | 10-K |
| FY 2016 | 2015-09-30 | -0.12 | 2017-03-02 | 10-K |
| FY 2016 | 2015-06-30 | -0.19 | 2017-03-02 | 10-K |
| FY 2016 | 2015-03-31 | -0.17 | 2017-03-02 | 10-K |
| Q3 2015 | 2014-09-30 | -0.23 | 2015-11-05 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.